SecBot SecBot
EFFECT ·Filed Mar 30, 2026

DRIO

DarioHealth Corp.
NEUTRAL
Impact 3/10
Horizonweeks Processed7mo ago SEC9999999995-26-000969
IPO/offering going effective
Actionable Insight • Neutral

Monitor for future prospectus supplements that will disclose specific terms of any securities offering, including pricing, size, and use of proceeds. The $100M shelf creates a dilution overhang that may pressure the stock until utilized or expired.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d ⚠ clustered
DRIO ▼ -24.91% at T+60d
NEUTRAL call -24.91% · α vs SPY -41.40% · entry $8.19 → $6.15
Entry = T+0 close
Mar 30, 2026
via day close
T+1d
-2.08%
call -2.08% · α -4.97%
$8.02
settled 7mo ago
T+5d
-22.22%
call -22.22% · α -26.52%
$6.37
settled 7mo ago
T+20d
-9.65%
call -9.65% · α -22.24%
$7.40
settled 6mo ago
T+60d
-24.91%
call -24.91% · α -41.40%
$6.15
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

DarioHealth Corp.'s S-3 shelf registration statement has become effective, allowing the company to offer up to $100 million in securities, including common stock, preferred stock, warrants, and units, over time. This creates a potential for future dilution as shares can be sold at management's discretion based on market conditions.

Key Facts

  • S-3 shelf registration effective as of March 27, 2026
  • Authorized offering size: $100,000,000
  • Securities may include common stock, preferred stock, warrants, and units
  • Offering will be conducted on a delayed or continuous basis under Rule 415
  • Company will not receive proceeds from resale of shares by selling stockholders in prior related shelf takedowns

Financial Impact

$100,000,000 in potential future dilution from primary offerings; exact financial impact depends on timing, pricing, and structure of future takedowns

dilutionequitymarket capshare count

Risk Factors

  • Future equity offerings could significantly dilute existing shareholders
  • Offerings may occur at prices below current market value, especially in weak market conditions

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-000969
Document: 9999999995-26-000969-index.html9999999995-26-000969
Document: 9999999995-26-000969.txt9999999995-26-000969
4 reports for DRIO
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for DRIO — sortable, filterable
TypeNow
Jul 22, 2026
13w ago
424B5
BEARISH ★ 6/10
$7.47 $5.13▲ +31.33%▲ +35.88%$3.48 (+53.41%)
Apr 13, 2026
28w ago
3
NEUTRAL ★ 2/10
$7.56 $7.00▼ −7.41%▼ −15.93%$3.48 (−53.97%)
Apr 13, 2026
28w ago
8-K
NEUTRAL ★ 3/10
$7.34 $7.22▼ −1.63%▼ −10.56%$3.48 (−52.59%)
Mar 30, 2026
30w ago
EFFECT
NEUTRAL ★ 3/10
$8.19 $6.15▼ −24.91%▼ −41.40%$3.48 (−57.51%)
Showing 4 of 4

US Market Status

Market Closed — Opens Wed (16h 34m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 30, 2026